The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome

Zhiguo Zhang1, Shanshan Zhou, Xin Jiang

  • 1Departments of Cardiovascular Disorders, Gerontology & Radiation Oncology at the First Hospital, Jilin University, Changchun, 130021, China.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a dual role in metabolic health. While Nrf2 can protect against cardiovascular disease, its dysregulation is linked to insulin resistance and metabolic syndrome.

Area of Science:

  • Metabolic signaling pathways
  • Oxidative stress and redox biology
  • Cardiovascular disease prevention

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of antioxidant and cytoprotective genes.
  • Nrf2 signaling is implicated in metabolic syndrome and associated cardiovascular complications.
  • Contradictory roles of Nrf2 in insulin sensitivity and resistance have been reported, suggesting a complex regulatory network.

Purpose of the Study:

  • To review the latest findings on Nrf2-mediated signaling mechanisms.
  • To elucidate the role of Nrf2 in metabolic homeostasis and insulin sensitivity.
  • To explore the impact of redox balance on Nrf2's function in metabolic pathways.

Main Methods:

  • Literature review of recent studies on Nrf2 signaling.
  • Analysis of experimental data linking Nrf2 to insulin resistance, adipogenesis, and oxidative stress.
  • Synthesis of evidence regarding the dual role of Nrf2 in metabolic regulation.

Main Results:

  • Nrf2 deficiency can ameliorate insulin resistance and adipogenesis.
  • Nrf2 overexpression can exacerbate insulin resistance under specific conditions.
  • Redox homeostasis critically influences Nrf2's effects on insulin signaling, with reactive oxygen species having context-dependent roles.

Conclusions:

  • Nrf2's impact on insulin sensitivity is complex and depends on cellular context and redox status.
  • Understanding Nrf2's regulation of redox balance is key to resolving its contradictory effects on metabolic health.
  • Further research into Nrf2-mediated signaling is crucial for developing therapeutic strategies for metabolic disorders.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.6K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2